Joseph Thome's Stock Ratings

TD Cowen Analyst

Joseph Thome is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025

Overall Average Return

-17.8%

Smart Score

34.5%

Overall Average Return Percentile

14th

Number of Ratings

28
Buy NowGet Alert
11/25/2024VRDNBuy Now
Viridian Therapeutics
$15.54
Joseph Thome34%
Initiates → BuyGet Alert
10/25/2024MRNSBuy Now
Marinus Pharma
Joseph Thome34%
DowngradeBuy → HoldGet Alert
10/21/2024UTHRBuy Now
United Therapeutics
$317.5025.98%
Joseph Thome34%
$350 → $400MaintainsBuyGet Alert
07/11/2024UTHRBuy Now
United Therapeutics
$317.5010.24%
Joseph Thome34%
$270 → $350MaintainsBuyGet Alert
07/02/2024RAPPBuy Now
Rapport Therapeutics
$9.70
Joseph Thome34%
Initiates → BuyGet Alert
06/18/2024AVTEBuy Now
Aerovate Therapeutics
$2.51
Joseph Thome34%
DowngradeBuy → HoldGet Alert
06/17/2024ALKSBuy Now
Alkermes
$33.202.41%
Joseph Thome34%
→ $34Initiates → BuyGet Alert
04/17/2024ITCIBuy Now
Intra-Cellular Therapies
$131.89-31.76%
Joseph Thome34%
$80 → $90MaintainsBuyGet Alert
04/08/2024PRMEBuy Now
Prime Medicine
$1.81
Joseph Thome34%
Initiates → BuyGet Alert
03/05/2024MGXBuy Now
Metagenomi
$1.63
Joseph Thome34%
Initiates → OutperformGet Alert
03/01/2024PTCTBuy Now
PTC Therapeutics
$56.61-47.01%
Joseph Thome34%
$32 → $30MaintainsMarket PerformGet Alert
12/11/2023ITCIBuy Now
Intra-Cellular Therapies
$131.89-43.13%
Joseph Thome34%
→ $75Initiates → OutperformGet Alert
12/08/2023CEREBuy Now
Cerevel Therapeutics Hldg
Joseph Thome34%
→ $45DowngradeOutperform → Market PerformGet Alert
10/18/2023EVLOBuy Now
Evelo Biosciences
$0.00
Joseph Thome34%
DowngradeOutperform → Market PerformGet Alert
05/24/2023PTCTBuy Now
PTC Therapeutics
$56.61-29.34%
Joseph Thome34%
$47 → $40MaintainsMarket PerformGet Alert
04/10/2023CEREBuy Now
Cerevel Therapeutics Hldg
Joseph Thome34%
Initiates → OutperformGet Alert
01/05/2023YMABBuy Now
Y-mAbs Therapeutics
$5.09
Joseph Thome34%
DowngradeOutperform → Market PerformGet Alert
12/12/2022XENEBuy Now
Xenon Pharmaceuticals
$34.60
Joseph Thome34%
Initiates → OutperformGet Alert
12/12/2022ACRVBuy Now
Acrivon Therapeutics
$5.02
Joseph Thome34%
Initiates → OutperformGet Alert
10/10/2022THRDBuy Now
Third Harmonic Bio
$3.52
Joseph Thome34%
Initiates → OutperformGet Alert
06/29/2022AXSMBuy Now
Axsome Therapeutics
$120.368.01%
Joseph Thome34%
$120 → $130MaintainsOutperformGet Alert
06/28/2022EPZMBuy Now
Epizyme
Joseph Thome34%
→ $1.5DowngradeOutperform → Market PerformGet Alert
01/31/2022NTLABuy Now
Intellia Therapeutics
$8.88
Joseph Thome34%
Initiates → OutperformGet Alert
11/23/2021TRDABuy Now
Entrada Therapeutics
$10.18
Joseph Thome34%
Initiates → OutperformGet Alert
07/26/2021AVTEBuy Now
Aerovate Therapeutics
$2.51
Joseph Thome34%
Initiates → OutperformGet Alert
07/15/2021ALLKBuy Now
Allakos
$0.24
Joseph Thome34%
Initiates → OutperformGet Alert
07/01/2020MRNSBuy Now
Marinus Pharma
Joseph Thome34%
Initiates → OutperformGet Alert
04/14/2020AXSMBuy Now
Axsome Therapeutics
$120.36-21.07%
Joseph Thome34%
→ $95Initiates → OutperformGet Alert